PHE - Corporate - Acute Drug Harms Surveillance and Early Warning System in UK Emergency Departments

Public Health England (PHE) is seeking to commission an external partner with an existing system and / or capability to deliver an opioid and new psychoactive substances (NPS) clinical harms surveillance programme. The programme will:

• rapidly detect any incident involving synthetic opioids in the heroin or cocaine markets;
• monitor the emergence of a synthetic opioid market as seen in North America;
• identify health harms associated with toxicity from emerging/new NPS, such as synthetic cannabinoids.

Additional information:

Proposals should be emailed to …@phe.gov.uk and include the following documentation / information:

1. supporting statement setting out and establishing suitability to undertake the project, including evidence of national/international work within the field of laboratory analysis of illicit drugs/clinical toxicology and programme management;

2. project outline with details of methodology including proposed strategy for laboratory analysis (offering the most cost-effective options most likely to ensure signals are picked up), timescales, and risks;

3. budget (including detailed breakdown of spend);

4. project team CVs.

Word count (excluding project team CVs and budget) is a max of 4,000 words.

Tender Documents

• Opportunity notice on Contracts Finder → — Tender notice
• Specification Document → — Tender notice